
Cutting cost and time – HCV immunoassay predicts clinical response rate to antiviral treatment
- Antiviral drugs for HCV are effective but expensive
- Immunoassay can predict response to antiviral drugs
- Significant reduction of long-term treatment cost
Cutting cost and time – HCV immunoassay predicts clinical response rate to antiviral treatment
Immunotherapy for Chronic Liver Diseases
2 of 109 Tech Offers
Contact a specific team member for individual topics via the Team section or simply use our contact form. You can also click on the button and drop us a line.